In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes

Transplantation

Volumn 65, Issue 10, 1998, Pages 1365-1370

  Contassot, Emmanuel ^a,b   Murphy, William ^c   Angonin, Régis ^a   Pavy, Jean Jacques ^a   Bittencourt, Marcelo C ^a   Robinet, Éric ^a   Reynolds, Craig W ^c   Cahn, Jean Yves ^a   Hervé, Patrick ^a   Tiberghien, Pierre ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Lab de Therapeutique Immuno Molec   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; GRAFT VERSUS HOST REACTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; GENE TRANSFER TECHNIQUES; GRAFT VS HOST DISEASE; HERPES SIMPLEX; INTERLEUKIN-2; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; THYMIDINE KINASE; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032571988     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805270-00014     Document Type: Article

References (22)

1. Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120.
2. Tiberghien P. Use of suicide genes in gene therapy. J Leukoc Biol 1994; 56: 203.
3. Kit S, Leung WC, Jorgensen GN, Dubbs DR. Distinctive properties of thymidine kinase isozymes induced by human and avian herpes virus. Int J Cancer 1974; 14: 598.
4. Tiberghien P, Reynolds CW, Keller J, et al. Ganciclovir treatment of herpes simplex kinase-transduced primary T-lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 1994; 84: 1333.
5. Tiberghien P, Cahn JY, Contassot E, Reynolds CW, Hervé P. Gene transfer applied to the modulation of alloreactivity. Hematol Cell Ther 1996; 38: 221.
6. Tiberghien P, Cahn JY, Brion A, et al. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I study. Hum Gene Ther 1997; 8: 615.
7. Lerner KG, Kao GF, Storb R, et al. Histopathology of the graft-versus-host reaction in human recipients of marrow from HLA matched sibling donor. Transplant Proc 1974; 6: 367.
8. Sale GE, Shulman HM. The pathology of bone marrow transplantation. Atlanta, GA: Masson Publishing USA, 1984.
9. Anderson WF. Human gene therapy. Science 1992; 256: 808.
10. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation 1995; 60: 355.
11. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449.
12. Leonardo JL. Interleukin-2 programs mouse T lymphocytes for apoptosis. Nature 1991; 353: 858.
13. Novelli F, Di Pierro F, Di Celle PF, et al. Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis. J Immunol 1994; 152: 496.
14. Ferrara JL, Cooke KR, Pan L, Krenger W. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996; 14: 473.
15. Heremans H, Dijkmans R, Sobis H. Regulation by interferons of the local inflammatory response to lyposaccharide. J Immunol 1987; 138: 4175.
16. Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994; 84: 3540.
17. De Witt D, Van Mechelen M, Zanin C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150: 361.
18. Krenger W, Snyder KM, Byon JCH, Falzarano G, Ferrara JLM. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental graft-versus-host disease. J Immunol 1995; 155: 585.
19. Salgame P, Abrams JS, Clayberger, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279.
20. Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J Immunol 1996; 157: 4811.
21. Brok HP, Heidt PJ, Van der Meide PH, Zurcher C, Vossen JM. Interferon-γ prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol 1993; 151: 6451.
22. Otten G, Wilde DB, Prystowsky MB, et al. Cloned helper T lymphocytes exposed to interleukin 2 become unresponsive to antigen and concanavalin A but not to calcium ionophore and phorbol ester. Eur J Immunol 1986; 16: 217.